Network News

X My Profile
View More Activity

Pfizer Settlement Nets District $430,372

The District will get a $430,372 chunk of a $33 million settlement that 42 states reached with Pfizer, which also agreed to a record $2.3 billion settlement for improperly marketing drugs.

The city's agreement involves Geodon, an antipsychotic drug that the city and other jurisdictions said was marketed for pediatric use, and use at dosage levels that had not been approved by the U.S. Food and Drug Administration, according to a news release from the Office of the Attorney General.

"This case demonstrates that the District and the states will continue to monitor the pharmaceutical industry for inappropriate and illegal promotion of the off-label use of its products," Attorney General Peter Nickles said in the news release.

The settlement highlights issues that Council member David A. Catania (I-At Large) raised with the controversial SafeRx Act, which narrowly passed the council in January. Catania, chairman of the Committee on Health, has repeatedly spoken about drug companies marketing medicines for "off-label" uses.

-- Nikita Stewart

By Christopher Dean Hopkins  |  September 3, 2009; 11:09 AM ET
Categories:  Nikita Stewart  
Save & Share:  Send E-mail   Facebook   Twitter   Digg   Yahoo Buzz   Del.icio.us   StumbleUpon   Technorati   Google Buzz   Previous: D.C. Archbishop Goes on the Offensive on Gay Marriage
Next: Update: Hawkins Chosen to Head WASA

Comments

Has it been stolen yet?

Posted by: concernedaboutdc | September 3, 2009 1:34 PM | Report abuse

I don't understand (well, I really DO, but I don't see why) why the District gets this moola, and not the people who were affected.

Posted by: MSinVA | September 3, 2009 6:18 PM | Report abuse

The comments to this entry are closed.

 
 
RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company